[Efficacy and safety of daratumumab in patients with relapsed/refractory multiple myeloma].
Zhao AL, Tang WJ, Li Y, Liao Y, Li H, Wang J, Shen K, Yang YF, Xu J, Zhang L, Zheng YH, Niu T.
Zhao AL, et al.
Zhonghua Yi Xue Za Zhi. 2022 Nov 8;102(41):3304-3311. doi: 10.3760/cma.j.cn112137-20220311-00498.
Zhonghua Yi Xue Za Zhi. 2022.
PMID: 36319183
Chinese.